Company Ticker News October 18, 2021Emergent BioSolutions to Release Third Quarter 2021 Financial Results and Conduct a Conference Call on November 4, 2021 0 0 Share
Press Release October 15, 2021Emergent BioSolutions Announces Initiation of Pivotal Phase 3 Study Evaluating the Safety and Immunogenicity of Its Single-Dose Chikungunya Vaccine Candidate, CHIKV VLP 0 0 Share
Company Ticker News September 15, 2021Emergent (EBS) Inks COVID-19 Manufacturing Deal With Providence 0 0 Share
Company Ticker News September 14, 2021Emergent Secures Contract To Manufacture Providence Therapeutics' COVID-19 Vaccine Candidate 0 0 Share
Press Release September 14, 2021Emergent BioSolutions Secures Multi-Year Development and Manufacturing Agreement with Providence Therapeutics for its mRNA COVID-19 Vaccine Candidate, PTX-COVID19-B 0 0 Share
Company Ticker News September 2, 2021Emergent BioSolutions: Positive Outlook Despite Current Lawsuit 0 0 Share
Company Ticker News August 25, 2021Emergent BioSolutions' COVID-19 Plasma Candidate To Be Tested As Outpatient Treatment 0 0 Share
Press Release August 25, 2021Emergent BioSolutions' COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19 0 0 Share
Company Ticker News July 30, 2021Emergent (EBS) Misses on Q2 Earnings, to Restart Bayview Unit 0 0 Share
